DEVELOPMENT OF A NORMAL RANGE FOR FIRST TRIMESTER PREGNANCY INTRACRANIAL TRANSLUCENCY MEASUREMENTS
Keywords:Antenatal, first trimester, intracranial translucency, reference range, ultrasound
Intracranial translucency (IT) by ultrasound in the first trimester is used in screening for open spina bifida, which is predominantly seen in the second trimester morphology ultrasound. IT has been used in many countries, including Asian and European countries. The aim of this study is to generate an IT normal range and to correlate IT measurements and neurological system abnormalities identified during second trimester ultrasound scan. A retrospective cohort study was performed using 199 foetal records taken from nuchal translucency (NT) clinic, from 1 June 2016 to 30 November 2019. Intracranial translucency (IT) measurements were assessed using existing nuchal translucency (NT) images of the foetuses aged 11 weeks to 13 weeks and 6 days of gestational age, where the foetal measurements taken for this study were between 45 and 84 mm. Eighteen samples were excluded, leaving only 181 samples that met the set criteria were used to establish the IT normal range. Inclusion criteria for this study involved all pregnant women with singleton pregnancies who had undergone NT scan with gestational ages ranging from 11 to 13 + 6 days. Based on the normal range value created, a total of 144 samples were normal foetuses, while the other 37 foetuses had various ultrasound abnormalities in the second trimester of pregnancy with no open spina bifida found. The results obtained exhibit linearly increased IT measurements with increasing crown-rump length (CRL), gestational age (GA), and nuchal translucency (NT).
2. Rodriguez MR, Fernandez VMV, Ten PM, et al. Fetal MRI in CNS abnormalities. Relevant issues for obstetricians. Revision Articles International Collaboration RAR. 2010; 74(4):4.
3. Molina-Giraldo SM, Perez-Olivo JL, Arias JLR, et al. Normal intracranial translucency values during the first trimester of gestation in a Latin American population. J Ultrasound Med. 2016; 35(10):2231-6.
4. Nicolaides KH, Campbell S, Gabbe SG, et al. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet. 1986; 2:72–4.
5. Van den Hof MC, Nicolaides KH, Campbell J, et al. Evaluation of the lemon and banana signs in one hundred and thirty fetuses with open spina bifida. Am J Obstet Gynecol. 1990; 162:322–7.
6. Ghi T, Pilu G, Falco P, et al. Prenatal diagnosis of open and closed spina bifida. Ultrasound Obstet Gynecol. 2006; 28:899–903.
7. Nizard J, Bernard JP, Ville Y. Fetal cystic malformations of the posterior fossa in the first trimester of pregnancy. Fetal Diagn Ther. 2005; 20(2):146-51.
8. Lachmann R, Chaoui R, Moratalla J, et al. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn. 2011; 31:103–6.
9. Lachmann R, Sinkovskaya E, Abuhamad A. Posterior brain in fetuses with Dandy-Walker malformation with complete agenesis of the cerebellar vermis at 11–13 weeks: a pilot study. Prenat Diagn. 2012; 32:765–9.
10. Lee MY, Won HS, Hyun MK, et al. One case of increased intracranial translucency during the first trimester associated with the Dandy-Walker variant. Prenat Diagn. 2012; 32(6):602-3.
11. Grande M, Arigita M, Borobio V, et al. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound Obstet Gynecol. 2012; 39:157–63.
12. Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn. 2011; 31:90–102.
13. Artunc-Ulkumen B, Pala GH, Uyar Y, et al. Normal range of intracranial translucency in healthy Turkish pregnancies and its association with first-trimester maternal serum biochemistry and ductus venosus Pulsatility Index. Ginekol Pol. 2014; 85:738-41.
14. Papastefanou I, Souka AP, Pilalis A, et al. Fetal intracranial translucency and cisterna magna at 11 to 14 weeks: reference ranges and correlation with chromosomal abnormalities. Prenat Diagn. 2011; 31:1189-92.
15. Chen M, Chen H, Yang X, et al. Normal range of intracranial translucency (IT) assessed by three-dimensional ultrasound at 11+0 to 13+6 weeks in a Chinese population. J Matern Fetal Neonatal Med. 2012; 25(5): 489-92.
16. Egle D, Strobl I, Weiskopf-Schwendinger V, et al. Appearance of the fetal posterior fossa at 11 + 3 to 13 + 6 gestational weeks on transabdominal ultrasound examination. Ultrasound Obstet Gynecol. 2011; 38: 620–4.
17. Volpe P, Contro E, Fanelli T, et al. Appearance of fetal posterior fossa at 11-14 weeks in fetuses with Dandy-Walker malformation or chromosomal anomalies. Ultrasound Obstet Gynecol. 2016; 47: 720-25.
18. Fong KW, Toi A, Okun N, et al. Retrospective review of diagnostic performance of intracranial translucency in detection of open spina bifida at the 11–13-week scan. Ultrasound Obstet Gynecol. 2011; 38: 630-4.
19. Adiego B, Illescas T, Martinez-Ten P, et al. Intracranial translucency at 11-13 weeks of gestations: prospective evaluation and reproducibility of measurements. Prenat Diagn. 2012; 32:259-63.
20. Beamon CJ, Stuebe AM, Wolfe HM. Factors influencing visualization of the intracranial translucency during first-trimester screening for aneuploidy. Am J Perinatol. 2012; 29(7):503-8.
21. Bardi F, Smith E, Kuilman M, et al. Early detection of structural anomalies in a primary care setting in the Netherlands. Fetal Diagn Ther. 2019; 46:12-9.
22. Rossi AC, Prefumo F. Accuracy of ultrasonography at 11–14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol. 2013; 122(6):1160–7.
23. Souka AP, Pilalis A, Kavalakis Y. et al. Assessment of fetal anatomy at the 11–14-week ultrasound examination. Ultrasound Obstet Gynecol. 2004; 24(7):730–4.
24. Van Mieghem T, Hindryckx A, Van Calsteren K. Early fetal anatomy screening: who, what, when and why? Curr Opin Obstet Gynecol. 2015; 27(2):143–50.
25. Karim JN, Roberts NW, Salomon LJ, et al. Systematic review of first trimester ultrasound screening in detecting fetal structural anomalies and factors affecting screening performance. Ultrasound Obstet Gynecol. 2017; 50:429–41.
26. Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks assessment. Prenat Diagn. 2011; 31:3-6.
27. Salomon LJ, Alfirevic A, Bilardo CM. et al. ISUOG Clinical Standards Committee. Practice guidelines: performance of first-trimester fetal ultrasound scan Ultrasound Obstet Gynecol. 2013; 41:102–13.
28. Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther. 2011; 29:183–9.
29. Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn. 2011; 31:90–102.
30. Nanthakomon T, Pongrojpow D, Chantasennanont A, et al. Nomogram of intracranial translucency in the first trimester ultrasound of pregnant women at Thammasat University Hospital. J Med Assoc Thai. 2016; 99(Suppl 4):S32-6.
31. Vayna AM, Veduta A, Duta S, et al. Diagnosis of fetal structural anomalies at 11 to 14 weeks. J Ultrasound Med. 2018; 37(8):2063-73.
32. Vora NL, Romero ST, Ralston SJ, et al. Committee Opinion No. 682: Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol. 2016; 128:262–8.